AIDS therapy. New hope against blindness.
Cohen
J
J
D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy*; D000998:Antiviral Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D001766:Blindness / Q000209:etiology / Q000517:prevention & control*; D000077404:Cidofovir; D002986:Clinical Trials as Topic; D017726:Cytomegalovirus Retinitis / Q000150:complications / Q000188:drug therapy*; D003596:Cytosine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D004343:Drug Implants; D015774:Ganciclovir / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D016372:RNA, Antisense / Q000008:administration & dosage / Q000627:therapeutic use
D000998:Antiviral Agents; D004343:Drug Implants; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D016372:RNA, Antisense; D003596:Cytosine; D000077404:Cidofovir; D015774:Ganciclovir